-
Something wrong with this record ?
PLGA-based nanocarriers for combined delivery of colchicine and purpurin 18 in cancer therapy: Multimodal approach employing cancer cell spheroids
ALV. Zumaya, VS. Pavlíčková, S. Rimpelová, M. Štějdířová, M. Fulem, I. Křížová, P. Ulbrich, P. Řezanka, F. Hassouna
Language English Country Netherlands
Document type Journal Article
- MeSH
- Spheroids, Cellular drug effects MeSH
- Photochemotherapy methods MeSH
- Photosensitizing Agents administration & dosage chemistry pharmacology MeSH
- Colchicine * administration & dosage MeSH
- Polylactic Acid-Polyglycolic Acid Copolymer * chemistry MeSH
- Drug Delivery Systems methods MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Neoplasms drug therapy MeSH
- Nanoparticles administration & dosage MeSH
- Drug Carriers * chemistry MeSH
- Antineoplastic Agents administration & dosage chemistry pharmacology MeSH
- Drug Liberation * MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Improving the anticancer efficacy of chemotherapeutic drugs and photosensitizers requires innovative multifunctional nanoplatforms. This study introduces a chemo- and phototherapeutic drug delivery system (DDS) based on poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs), both PEGylated and non-PEGylated, with a mean size of 200 ± 75 nm. Colchicine (Colch) and purpurin18 (P18) were co-encapsulated into these NPs, and their in vitro drug release profiles were investigated. The anticancer potential of these systems was evaluated across various cell lines (i.e., CaCo-2, PC-3, MCF-7, and MRC-5 cells), demonstrating enhanced NP uptake by cancer cells compared to free drugs. Co-administration of Colch and P18 in 2D and 3D cell line models exhibited a synergistic effect, harnessing both chemotherapeutic and photodynamic effects, leading to higher cancer cell elimination efficacy. This newly developed multifunctional DDS presents a promising platform for combined chemo- and photodynamic therapy in cancer treatment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013870
- 003
- CZ-PrNML
- 005
- 20240905133429.0
- 007
- ta
- 008
- 240725e20240426ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2024.124170 $2 doi
- 035 __
- $a (PubMed)38679244
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Zumaya, Alma Lucia Villela $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 245 10
- $a PLGA-based nanocarriers for combined delivery of colchicine and purpurin 18 in cancer therapy: Multimodal approach employing cancer cell spheroids / $c ALV. Zumaya, VS. Pavlíčková, S. Rimpelová, M. Štějdířová, M. Fulem, I. Křížová, P. Ulbrich, P. Řezanka, F. Hassouna
- 520 9_
- $a Improving the anticancer efficacy of chemotherapeutic drugs and photosensitizers requires innovative multifunctional nanoplatforms. This study introduces a chemo- and phototherapeutic drug delivery system (DDS) based on poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs), both PEGylated and non-PEGylated, with a mean size of 200 ± 75 nm. Colchicine (Colch) and purpurin18 (P18) were co-encapsulated into these NPs, and their in vitro drug release profiles were investigated. The anticancer potential of these systems was evaluated across various cell lines (i.e., CaCo-2, PC-3, MCF-7, and MRC-5 cells), demonstrating enhanced NP uptake by cancer cells compared to free drugs. Co-administration of Colch and P18 in 2D and 3D cell line models exhibited a synergistic effect, harnessing both chemotherapeutic and photodynamic effects, leading to higher cancer cell elimination efficacy. This newly developed multifunctional DDS presents a promising platform for combined chemo- and photodynamic therapy in cancer treatment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kolchicin $x aplikace a dávkování $7 D003078
- 650 12
- $a kopolymer kyseliny glykolové a mléčné $x chemie $7 D000077182
- 650 12
- $a nosiče léků $x chemie $7 D004337
- 650 12
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné sféroidy $x účinky léků $7 D018874
- 650 _2
- $a nanočástice $x aplikace a dávkování $7 D053758
- 650 _2
- $a protinádorové látky $x aplikace a dávkování $x chemie $x farmakologie $7 D000970
- 650 _2
- $a fotochemoterapie $x metody $7 D010778
- 650 _2
- $a fotosenzibilizující látky $x aplikace a dávkování $x chemie $x farmakologie $7 D017319
- 650 _2
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a lékové transportní systémy $x metody $7 D016503
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavlíčková, Vladimíra Svobodová $u Faculty of Food and Biochemical Technology, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Rimpelová, Silvie $u Faculty of Food and Biochemical Technology, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic. Electronic address: silvie.rimpelova@vscht.cz
- 700 1_
- $a Štějdířová, Markéta $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Fulem, Michal $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Křížová, Ivana $u Faculty of Biotechnology, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Ulbrich, Pavel $u Faculty of Food and Biochemical Technology, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Řezanka, Pavel $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic
- 700 1_
- $a Hassouna, Fatima $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, 166 28 Prague 6, Czech Republic. Electronic address: fatima.hassouna@vscht.cz
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 657 (20240426), s. 124170
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38679244 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133423 $b ABA008
- 999 __
- $a ok $b bmc $g 2143592 $s 1225736
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 657 $c - $d 124170 $e 20240426 $i 1873-3476 $m International journal of pharmaceutics $n Int J Pharm $x MED00002359
- LZP __
- $a Pubmed-20240725